Firstkind’s recent publication of its Carbon Reduction Plan and sustainability progress is a textbook example of how healthcare companies can leverage sustainability not just as a checkbox, but as a…
The upcoming joint meeting between the CTTI/FDA Patient Engagement Collaborative (PEC) and the EMA Patients and Consumers Working Party (PCWP) signals a continued commitment to patient involvement in regulatory processes.…
The announcement from CEO Dave Rosa about the da Vinci 5’s rollout outpacing expectations is a clear signal that Intuitive Surgical continues to dominate the surgical robotics market. However, the…
The evolving complexity of VA claims is not just a bureaucratic hurdle—it is a clarion call for healthcare and medical marketing professionals to rethink how we support veterans navigating this…
The recent guide on NovoRapid Vial’s use underscores a persistent challenge in diabetes management: bridging clinical efficacy with practical patient adherence. While NovoRapid’s fast-acting profile is well-known, the educational content…
Zylox-Tonbridge’s decision to acquire German medical technology company Optimed signals a bold, if somewhat risky, expansion strategy that deserves closer scrutiny from industry insiders. While cross-border acquisitions are not uncommon…
Epiminder’s announcement of the first US implantation of its Minder System signals a pivotal moment in the epilepsy device landscape. As an industry professional, it’s clear this isn’t just a…
Ypsomed’s renewed commitment to self-injection delivery systems is a textbook example of a medical device company doubling down on its core competencies amid a rapidly evolving healthcare landscape. While this…
The weight management landscape is undergoing a seismic shift, yet many in healthcare marketing remain stuck in the outdated paradigm of calorie counting and exercise prescriptions. This simplistic narrative no…
Organon’s recent FDA approval to extend Nexplanon’s effective use from three to five years is a textbook example of how incremental regulatory wins can reshape market dynamics in the contraceptive…